Hans Friedrich Stabenau, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electrocardiography | 6 | 2023 | 6442 | 1.380 |
Why?
|
Vectorcardiography | 1 | 2023 | 43 | 0.930 |
Why?
|
Quinidine | 1 | 2019 | 57 | 0.710 |
Why?
|
Torsades de Pointes | 1 | 2020 | 78 | 0.690 |
Why?
|
Phenethylamines | 1 | 2019 | 96 | 0.690 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2020 | 789 | 0.670 |
Why?
|
Death, Sudden, Cardiac | 2 | 2023 | 1541 | 0.540 |
Why?
|
Geriatric Assessment | 2 | 2020 | 1372 | 0.490 |
Why?
|
Disability Evaluation | 3 | 2020 | 1827 | 0.490 |
Why?
|
Heart Ventricles | 3 | 2023 | 3821 | 0.470 |
Why?
|
Arrhythmias, Cardiac | 2 | 2021 | 2268 | 0.440 |
Why?
|
Heart Rate | 2 | 2023 | 4091 | 0.440 |
Why?
|
Recovery of Function | 2 | 2020 | 2925 | 0.410 |
Why?
|
Hospice Care | 2 | 2016 | 672 | 0.390 |
Why?
|
Radiotherapy, Computer-Assisted | 1 | 2011 | 94 | 0.380 |
Why?
|
Surgical Procedures, Operative | 2 | 2020 | 1876 | 0.370 |
Why?
|
Pulmonary Embolism | 1 | 2023 | 2376 | 0.360 |
Why?
|
Sulfonamides | 1 | 2019 | 1938 | 0.350 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 15165 | 0.320 |
Why?
|
Algorithms | 2 | 2021 | 13881 | 0.280 |
Why?
|
Radiometry | 1 | 2011 | 800 | 0.270 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2011 | 1624 | 0.210 |
Why?
|
Palliative Care | 1 | 2015 | 3493 | 0.180 |
Why?
|
Potassium Channel Blockers | 1 | 2019 | 171 | 0.170 |
Why?
|
Risk Assessment | 2 | 2019 | 23338 | 0.170 |
Why?
|
Sodium Channel Blockers | 1 | 2019 | 176 | 0.160 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2023 | 719 | 0.160 |
Why?
|
Software | 2 | 2023 | 4443 | 0.160 |
Why?
|
Activities of Daily Living | 2 | 2018 | 2418 | 0.160 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 246 | 0.150 |
Why?
|
Pacemaker, Artificial | 1 | 2022 | 816 | 0.140 |
Why?
|
Aging | 1 | 2015 | 8664 | 0.130 |
Why?
|
Patient Admission | 2 | 2019 | 1380 | 0.120 |
Why?
|
Longitudinal Studies | 4 | 2020 | 13989 | 0.120 |
Why?
|
Cross-Over Studies | 1 | 2019 | 2029 | 0.120 |
Why?
|
Defibrillators, Implantable | 1 | 2022 | 1440 | 0.110 |
Why?
|
Hospices | 1 | 2016 | 265 | 0.110 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 5221 | 0.110 |
Why?
|
Acute Disease | 1 | 2023 | 7149 | 0.100 |
Why?
|
Aged | 8 | 2023 | 163280 | 0.100 |
Why?
|
Male | 10 | 2023 | 350118 | 0.090 |
Why?
|
Prognosis | 2 | 2023 | 29063 | 0.090 |
Why?
|
Frail Elderly | 1 | 2015 | 693 | 0.090 |
Why?
|
Survivors | 1 | 2020 | 2291 | 0.090 |
Why?
|
Female | 10 | 2023 | 380194 | 0.090 |
Why?
|
Respiratory Tract Diseases | 1 | 2015 | 722 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6489 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2759 | 0.080 |
Why?
|
Humans | 13 | 2023 | 744343 | 0.080 |
Why?
|
Needs Assessment | 1 | 2015 | 1147 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10943 | 0.070 |
Why?
|
Lung Neoplasms | 1 | 2011 | 13102 | 0.070 |
Why?
|
Prospective Studies | 4 | 2020 | 53288 | 0.070 |
Why?
|
Neurodegenerative Diseases | 1 | 2015 | 1061 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2019 | 12026 | 0.070 |
Why?
|
Reproducibility of Results | 1 | 2023 | 19905 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2019 | 57776 | 0.060 |
Why?
|
Radiotherapy Dosage | 1 | 2011 | 2879 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3158 | 0.060 |
Why?
|
Independent Living | 2 | 2020 | 568 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2020 | 21746 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5137 | 0.050 |
Why?
|
Incidence | 1 | 2020 | 20947 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2019 | 63114 | 0.050 |
Why?
|
Time Factors | 3 | 2020 | 40075 | 0.050 |
Why?
|
Middle Aged | 3 | 2023 | 213383 | 0.040 |
Why?
|
Disease Progression | 1 | 2015 | 13284 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2023 | 77449 | 0.040 |
Why?
|
Heart Failure | 1 | 2019 | 10900 | 0.030 |
Why?
|
Cohort Studies | 2 | 2016 | 40561 | 0.030 |
Why?
|
United States | 2 | 2020 | 69872 | 0.030 |
Why?
|
Urologic Diseases | 1 | 2016 | 244 | 0.030 |
Why?
|
Dizziness | 1 | 2016 | 251 | 0.030 |
Why?
|
Nausea | 1 | 2016 | 673 | 0.030 |
Why?
|
Muscle Weakness | 1 | 2016 | 413 | 0.030 |
Why?
|
Vomiting | 1 | 2016 | 636 | 0.030 |
Why?
|
Edema | 1 | 2016 | 789 | 0.030 |
Why?
|
Disabled Persons | 1 | 2020 | 1212 | 0.020 |
Why?
|
Diarrhea | 1 | 2016 | 1348 | 0.020 |
Why?
|
Chest Pain | 1 | 2016 | 1114 | 0.020 |
Why?
|
Memory Disorders | 1 | 2016 | 1184 | 0.020 |
Why?
|
Vision Disorders | 1 | 2016 | 1058 | 0.020 |
Why?
|
Fatigue | 1 | 2016 | 1531 | 0.020 |
Why?
|
Dyspnea | 1 | 2016 | 1303 | 0.020 |
Why?
|
Inpatients | 1 | 2019 | 2518 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1797 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9313 | 0.020 |
Why?
|
Neoplasms | 1 | 2015 | 21683 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3114 | 0.020 |
Why?
|
Adult | 1 | 2019 | 214055 | 0.020 |
Why?
|
Risk Factors | 2 | 2020 | 72290 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15226 | 0.010 |
Why?
|
Depression | 1 | 2016 | 7766 | 0.010 |
Why?
|